Navigation Links
Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor
Date:10/21/2010

d twice daily over 48-weeks. Secondary objectives include the assessment of antiviral activity of '572 compared to RAL at 96-weeks, to compare the tolerability, long-term safety and antiviral and immunologic activity of '572 to RAL, and to evaluate viral resistance in subjects experiencing virological failure.

SAILING Study Design (ING111762) SAILING is a Phase III, randomized, double-blind, active-controlled, multicenter, parallel group, non-inferiority study. The study will include approximately 688 HIV-1 infected treatment-experienced, integrase-naive subjects.  The non-inferiority study will assess the antiviral efficacy of '572 compared to RAL.

The primary objective for SAILING will be to demonstrate the antiviral efficacy of '572 50mg once-daily compared to RAL 400mg twice-daily both in combination with a background regimen consisting of one to two fully active agents at 48-weeks. Secondary objectives will evaluate the long-term antiviral activity, pharmacokinetics (PK), the relationship between PK and antiviral activity, tolerability and safety of '572 versus RAL.

About Shionogi-ViiV Healthcare LLC'572 is the lead compound in Shionogi-ViiV Healthcare LLC. It is currently the only once-daily, unboosted integrase inhibitor in Phase III clinical development. Shionogi-ViiV Healthcare LLC is also developing other second-generation integrase inhibitors, including S/GSK1265744, currently in Phase II development.

About ViiV Healthcare ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (NYSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with HIV. Our aim is to take a deeper and broader interest in HIV/AIDS than any company has done before and take a new approac
'/>"/>

SOURCE Shionogi-ViiV Healthcare LLC
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. HealthSport Enters Letter of Intent With CURE Pharmaceutical for Joint Development of Unique Pediatric Malaria Drug Product and Other Healthcare Related Products
2. McNeil Consumer Healthcare Announces Voluntary Recall of One Product Lot of TYLENOL® 8 Hour Caplets 50 Count Sold in the United States and Puerto Rico
3. Sen. Harry Reid to Medco Employees: Technology and Innovation Integral to Sustainable Healthcare Reform and Nevadas Future
4. Janam Introduces Mobile Healthcare Product Line
5. Express Scripts Unveils New Opportunities to Drive Down Healthcare Costs; Presents Five Studies at Academy of Managed Care Pharmacy Conference
6. Netsmart Technologies is First Behavioral Healthcare Software Provider to Pass Final Rule ARRA Certification Tests
7. Webcast Alert: CEL-SCI Corp. (CVM) Announces the Biotech, Healthcare and Pharma Virtual Conference
8. Healthcare Providers Gain Control of Demand Channels With GHX Procurement Suite; 12 Percent Supply Spend Savings Achievable
9. ADVENTRX to Participate in Informed Investors Forum Biotech, Healthcare & Pharma Virtual Conference on October 13
10. Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya
11. Aging of America: Demographics of Demand and Profits in Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... -- The new 13-valent pneumococcal conjugate vaccine (PCV13) appears ... prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), ... Vaccine. The U.S. Food and Drug Administration ... series of trials. These trials found that PCV13, which ... the previously used PCV7, did not increase the risk ...
(Date:5/22/2013)... -- Pomerantz Grossman Hufford Dahlstrom ... investors of Intuitive Surgical, Inc. ("Intuitive Surgical" or the ... purchased Intuitive Surgical common stock between October 19, 2011 ... are advised to contact Robert S. Willoughby ... 237. The investigation concerns whether Intuitive Surgical ...
(Date:5/22/2013)... Hemoglobin A1C levels increased over a ... diabetes, while modest improvements in A1C control has ... lead to substantial healthcare cost savings, according to ... Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual International ... Valeritas, makers of the V-Go ® insulin ...
Breaking Medicine Technology:Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6
... 2010 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: ... adopted at its annual general meeting of shareholders ... (Logo: http://photos.prnewswire.com/prnh/20040705/CNM002LOGO) (Logo: ... PharmaTech shareholders approved the re-election of incumbent Class ...
... 2010 Abaxis, Inc. (Nasdaq: ABAX ), ... today announced the release of a new Piccolo® reagent ... disc will be used by healthcare professionals in conjunction ... of this new panel configuration, U.S. healthcare professionals can ...
Cached Medicine Technology:WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting 2Abaxis Increases Reagent Disc Offering for Physician Office Market With Release of BioChemistry Panel Plus 2Abaxis Increases Reagent Disc Offering for Physician Office Market With Release of BioChemistry Panel Plus 3
(Date:5/22/2013)... 22, 2013 Zensah® Compression Apparel released ... article titled "Breast pain while running affects ... could help." According to the article, a British ... substantial amount suffer from breast pain while running but ... the issue. , Zensah emphasizes the importance for ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 People in the ... is leading to water shortages. In much of the world, ... to water advocate, Sharon Kleyne. She warns against taking water ... water that is available so easily in the United States. ... Power of Water radio show, heard live or by podcast ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Diversity Focus ... Handicap This! The performance promotes awareness that physical ... The Handicap This! performance will be held Friday, June ... School auditorium. Tickets for Handicap This! can be ... helps audiences measure the level to which their mind ...
(Date:5/22/2013)... University of Michigan study challenges previous research that ... , The study, a collaboration between researchers at ... looks deeper into the controversial argument over whether ... for pitchers of the same race. It found ... Jason Winfree, associate professor of sport management at ...
(Date:5/22/2013)... may be reaping enormous income for patients whose ... contracted in their intensive care units. , In ... American Journal of Medical Quality , the ... an avoidable central line-associated bloodstream infection (CLABSI) costs ... a similar infection-free patient. Moreover, hospitals earn nearly ...
Breaking Medicine News(10 mins):Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 3Health News:Water Advocate Sharon Kleyne Announces Water Conservation Appreciation 2Health News:Handicap This! Comes to Marion, Iowa 2Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4
... at the University of Adelaide will focus on treatment ... and genetic variations between people. The Centre for ... researchers with strengths in blood cancers and solid tumours, ... Professor David Callen, the team will use tumour profiling ...
... -- The risk of burns increases over the holiday ... flammable decorations and using fireplaces and candles. "We ... and Christmas. Your holiday, which should be full of ... Guy, director of Vanderbilt Regional Burn Center in Nashville, ...
... research shows 63% of women age 50 and older ... 12-year study period. Predictors for persistent pain included higher ... osteoarthritis (OA). Details of this longitudinal study are available ... by Wiley-Blackwell on behalf of the American College of ...
... an important regulatory enzyme may slow the loss of ... neurodegenerative disorders. In a report receiving advance online ... Hospital (MGH)-based research team reports that increased expression of ... in the brain of a mouse model of HD ...
... , SATURDAY, Dec. 17 (HealthDay News) -- The ... at this time of year it is especially important to ... "Holiday get-togethers tend to lead people to consume sugary treats ... spokesperson for the Academy of General Dentistry, said in an ...
... for the treatment of breast cancer has been ... the U.S. as an alternative to standard whole-breast ... 16th in the Journal of the ... APBI recurrence (external beam radiation, intraoperative radiotherapy, brachytherapy ...
Cached Medicine News:Health News:New personalized treatment options for cancer 2Health News:Christmas Trees and Trappings Can Fan Fire Risk 2Health News:Knee pain common complaint in middle-aged and mature women 2Health News:Regulatory enzyme overexpression may protect against neurodegeneration in Huntington's disease 2Health News:Dentist Gives Advice to Keep Holiday Smiles Bright 2Health News:Advantages and motivations uncertain behind use of brachytherapy for breast cancer radiotherapy 2Health News:Advantages and motivations uncertain behind use of brachytherapy for breast cancer radiotherapy 3
The Riboprinter microbial characterization system provides the speed, accuracy and resolution needed to identify microorganisms and characterize them efficiently and consistently. These determination...
A versatile plate washer and/or dispenser that aspirates from the top down without immersing the aspirating tubes in the well, ensuring overflow protection. 5 programmable protocols....
The Finstrip 4 is an effective and reliable microplate washer offering high performance, simplicity and ease of use....
... 1575 immunowash microplate washer ... needle position to perform ... maximize wash efficiency. This ... choice of wash that ...
Medicine Products: